A Single Participant Exposed Twice to an Inflammatory Stimulus

Slides:

Advertisements

Similar presentations

Description of Each Study in the Cross Trial Safety Analysis Solomon SD, et al. Circulation 2008 [Epub Mar 31]

Advertisements

David N. Juurlink, et al. CMAJ 2009;180: (7) [Epub]

Nonsense Mutations in PCSK9 and Cardiovascular Risk Factors among 3363 Black Participants in the Study Jonathan C.Cohen, et al, N Engl J Med 2006;354:

Type 2 diabetes and high blood pressure How explosive is the cocktail?

Blood samples available from study participants with myocardial infarction and controls by ethnic origin Matthew J McQueen, et al. Lancet 2008; 372:

Frank B. Hu et al N Engl J Med 2004; 351: Body-Mass Index and Relative Risk of Death from All Causes during 24 Years of Follow-up.

Lars Sjöström et al N Engl J Med 2004; 351: Characteristics of the Subjects at the Time of Matching and at the Time of the Inclusion Examination.

Lancet 373: , 2009 Baseline Characteristics of Participants and Study Design of Clinical Trials to Compare Intensive glucose- lowering versus.

Demographic Characteristics of the Study Population - Part I Jenny N.Poynter et al N Engl J Med 2005;352:

Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.

The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. N Engl J Med 2006; available at: End pointActive therapy PlaceboRelative.

Mechanism of Action of Aspirin Carlo Patrono, et al, N Engl J Med 2005;353:

Enrollment and Outcomes Duckworth W, et al. N Engl J Med 2009;360:

Discontinuation of medication after nonfatal event: MI

Alcohol, Other Drugs, and Health: Current Evidence July–August 2017

Structure of Cis and Trans Fatty Acids

Copyright © 2014 American Medical Association. All rights reserved.

Flow of Individuals Through the Vitamin E and Vitamin C Components of the Physicians’ Health Study II Howard D. Sesso et al. JAMA 2008;300:

LEADER trial: Primary Outcome

Matched Case-Control Study

Markov model structure

Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.

Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people Dr Anoop Dinesh Shah, MRCP, Claudia Langenberg, PhD, Eleni.

Copyright © 2007 American Medical Association. All rights reserved.

TNT: Baseline and final LDL cholesterol levels

Adjusted relative mortality risk

Rounded incidence values (%) of renal and nonrenal events

PRECISION Trial design: Patients with arthritis and increased cardiovascular risk were randomized to celecoxib 100 mg twice daily (n = 8,072) vs. ibuprofen.

Study Design Ketil Lunde, et al. N Engl J Med 2006;355:

Adjusted odds ratio for hypoglycemia with gatifloxacin and levofloxacin compared with macrolide antibiotics Antibiotic Odds ratio of hypoglycemia 95% CI.

Preventive Angioplasty in Myocardial Infarction Trial

Bisphosphonate exposure and Atypical Femoral Fractures

P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

Risk of major congenital malformations among study infants according to fetal exposure to antihypertensives during first trimester alone* Variable ACE.

Hazard ratios for the primary end point by subgroup of achieved LDL cholesterol (adjusted for age, sex, baseline calculated LDL cholesterol, diabetes,

Relative risk reduction for incident hypertension associated with weight loss of 6.8 kg: The Framingham Study Cohort Risk reduction (%) Relative risk.

Cystatin C levels and risk of death from all causes

Risk for BMI outcome (%)

Potential mechanisms whereby statins may reduce the risk of stroke

Characteristics of elderly patients prescribed statins after acute myocardial infarction (AMI) in Quebec, Ontario and British Columbia - Part I Zheng.

Enrollment and Outcomes

Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people Dr Anoop Dinesh Shah, MRCP, Claudia Langenberg, PhD, Eleni.

Inclusion Criteria for Patients with Multiple Atherothrombotic Risk Factors and for Those with Established Cardiovascular Disease Deepak L.Bhatt, et al,

Baseline Characteristics of the Subjects

Baseline Characteristics According to Sex

Nat. Rev. Cardiol. doi: /nrcardio

A.V. Khera et al. N Engl J Med 2011;364:127-35

Baseline Characteristics of the Study Participants

Baseline Characteristics of the Subjects*

Women’s Health Study: Baseline Characteristics Part 1

Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.

Age-Standardized Rates of Death from Any Cause According to the Estimated GFR among 1,120,295 Ambulatory Adults Alan S.Go et al. N Engl J Med 2004; 351:

Characteristics of Participants in the Nurses Health Study According to Alcohol Intake Meir J.Stampfer et al N Engl J Med 2005;352:

Baseline Characteristics of Elderly Participants in the Cardiovascular Health Study,According to Quintiles of Cystatin C Michael G.Shlipak et al N Engl.

Baseline Characteristics of the Patients – Part I

Baseline Characteristics of the Patients - Part I

Associations between atmospheric chemistry transport model pollution concentrations at lags 0, 1 and 2 and myocardial infarction (% change in risk per.

Cumulative incidence of cardiovascular events according to medication group in participants of the 4D study with an LDL-C in its fourth quartile at baseline.

EMPA-REG OUTCOME: Cumulative incidence of the primary outcome

Associations between type of MI and incident HF

Genetic predisposition to CHD modifies the increased CHD risk associated with smoking (*) ORs adjusted for age, gender, total energy intake, alcohol intake,

Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.

Meta-analysis of risk ratios for percentage of patients who developed catheter-associated urinary tract infection, for intervention versus control groups,

Prasugrel versus clopidogrel; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

Orly Vardeny et al. JCHF 2016;4:

Hazard ratios, with 95% confidence intervals as floating absolute risks, as estimate of association between category of updated mean haemoglobin A1c concentration.

Prasugrel and ticagrelor versus clopidogrel; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial.

Hazard risks for incident dementia by diverse social relationship engagement score. The scores are calculated by adding the number of selected social relationship.

Proportions of the social isolation—AMI and stroke excess risk mediated by biological, behavioural, socioeconomic and health-related factors. Proportions.

Increased incidence rate ratio (IRR) and 95% confidence intervals (CI) for type-specific community-acquired infections across eGFR categories within 12.

Presentation transcript:

A Single Participant Exposed Twice to an Inflammatory Stimulus Liam Smeeth, et al N Engl J Med 2004; 351: 2611-8

Age-Adjusted Incidence Ratios of a First Myocardial Infarction in Risk Periods after Exposure to Vaccination or Infection Liam Smeeth, et al N Engl J Med 2004; 351: 2611-8

Age-Adjusted Incidence Ratios of a First Stroke in Risk Periods after Exposure to Vaccination or Infection Liam Smeeth, et al N Engl J Med 2004; 351: 2611-8

Age-Adjusted Incidence Ratios of a Recurrent Myocardial Infarction during Risk Periods after Exposure to Vaccination or Infection Liam Smeeth, et al N Engl J Med 2004; 351: 2611-8

Age-Adjusted Incidence Ratios of a Recurrent Stroke during Risk Periods after Exposure to Vaccination or Infection Liam Smeeth, et al N Engl J Med 2004; 351: 2611-8